Dr. Fussell represents a diverse array of clients in various intellectual property matters, including patent and trademark prosecution and litigation. She performs due diligence, freedom-to-operate, validity, and patentability analyses in the chemical and life sciences industries. She has a wide range of experience in the biotechnology, pharmaceutical, and chemical arts,...
Stay on top of the most interesting people across the Biohealth Capital Region who are developing new medicines, growing companies and making an impact on the industry.
5 Questions With...
Get to know the people who shape our region. Learn about their past, where they are now, and how they see the future playing out. Oh, and get a taste of their personality too!
5 Questions with Eric A. Stahlberg, PhD, Director Bioinformatics and Data Science, Frederick National Laboratory for Cancer Research
Dr. Eric Stahlberg is director of Biomedical Informatics and Data Science at the Frederick National Laboratory for Cancer Research (FNL). Stahlberg has been instrumental in establishing FNL’s high-performance computing initiative and in assembling scientific teams across multiple, complex organizations to advance predictive oncology.
These exclusive C-level interviews highlight the work being done by the companies they lead and their contributions to strengthen the BioHealth Capital Region.
John Mumm is a serial biotechnology entrepreneur who, as a young researcher, demonstrated the importance of the cytokine, interleukin -10 (IL-10), in activating the immune system to destroy tumors. That research led to the use of Pegylated IL-10 to treat patients with pancreatic cancer and other solid tumors through his...
Vita Therapeutics, freshly infused with $32 million in financing, is advancing a novel approach to treating a localized form of muscular dystrophy with a cell therapy that combines a gene correction and induced pluripotent stem cell (iPSC) technology.
People On The Move
Every career has milestones. Please share in the celebration of these individuals as they take on new challenges and work toward future successes.
RoosterBio Names Life Science Industry Leader, Timothy M. Kelly, Ph.D., as New Chief Executive Officer
RoosterBio Names Life Science Industry Leader, Timothy M. Kelly, Ph.D., as New Chief Executive Officer Share Article Dr. Kelly brings 15 years of executive-level experience to RoosterBio after having led several highly specialized life sciences manufacturing companies "What sets Tim apart is his deep technical knowledge in cell and gene...
With a goal of expanding manufacturing capabilities to meet the growing demands of cell and gene therapy production, The Center for Breakthrough Medicines (CBM) promoted Chief Operating Officer Joerg Ahlgrimm to the role of Chief Executive Officer. Ahlgrimm joined CBM last year after serving as Head of Global Operations Pharma...
Candidates for Hire
BioBuzz is curating an up to date database of the region’s top biotech professionals who have been pre-qualified and are confidentially open to new opportunities in the Biohealth Capital Region. Your next employee could be right here waiting to hear from you. Here’s how it works.
Access unlimited profiles and qualifications
Request access to evaluate as many candidates as you are interested in for FREE.
FREE to interview
Agree to our candidate engagement terms and pricing, then begin to schedule interviews and speak with candidates.
One-time fee-per-successful hire
Hire your next employee with ease. We help negotiate offers and give you a 60-day guarantee.